Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 19, 2017
Mon, December 18, 2017
[ Mon, Dec 18th 2017
] - WOPRAI
[ Mon, Dec 18th 2017
] - WOPRAI
[ Mon, Dec 18th 2017
] - WOPRAI
[ Mon, Dec 18th 2017
] - WOPRAI
[ Mon, Dec 18th 2017
] - WOPRAI
[ Mon, Dec 18th 2017
] - WOPRAI
Fri, December 15, 2017
[ Fri, Dec 15th 2017
] - WOPRAI
[ Fri, Dec 15th 2017
] - WOPRAI
David Risinger Upgraded (TEVA) to Hold on, Dec 15th, 2017
David Risinger of Morgan Stanley, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Dec 15th, 2017.
David has made no other calls on TEVA in the last 4 months.
There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 4 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
- Liav Abraham of "Citigroup" Maintained at Hold with Decreased Target to $13 on, Monday, November 13th, 2017
- Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
These are the ratings of the 2 analyists that currently disagree with David
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
- Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
